Nippon India Nifty Pharma ETF Units Exchange Traded Fund

Nippon India Nifty Pharma ETF Units Exchange Traded Fund is offered by Nippon, a leading player in the field of passive investments.

The total expense ratio of Nippon India Nifty Pharma ETF Units Exchange Traded Fund is 0.19%, which means that investors pay 19 INR per 10,000 INR in investment capital annually.

The ETF is listed in INR.

European investors may incur additional costs for currency exchange and transaction fees.

No, Nippon India Nifty Pharma ETF Units Exchange Traded Fund does not comply with the EU UCITS investor protection directives.

The P/E ratio of Nippon India Nifty Pharma ETF Units Exchange Traded Fund is 31.47.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund tracks the performance of the Nifty Pharma Index - INR - Benchmark TR Gross.

Nippon India Nifty Pharma ETF Units Exchange Traded Fund is domiciled in IN.

The fund was launched on 7/2/2021.

The Nippon India Nifty Pharma ETF Units Exchange Traded Fund mainly invests in Healthcare companies.

The NAV of Nippon India Nifty Pharma ETF Units Exchange Traded Fund amounts to 17.49 M INR.

The price-to-book ratio is 4.591.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.